Navigation Links
Ground Zero Pharmaceuticals, Inc. (GZP) Announces Expansion of Oncology Programs for Its Clients
Date:10/27/2011

IRVINE, Calif., Oct. 27, 2011 /PRNewswire/ -- GZP is announcing expansion of its client oncology programs, from strategic and regulatory consulting through product development and clinical trial execution, of pharmaceutical and biological therapies.  These include treatment vaccines, somatic cell and gene therapies, and novel small molecules.  Senior associates with oncology expertise in nonclinical, manufacturing, and clinical development provide clients with hands-on guidance throughout the FDA regulatory review process.  Firms in the US, Europe and Australia are actively working with GZP, in Phase 1 through Phase 3 clinical trials.

Dr. Evan B. Siegel, GZP's CEO, will be at BioEurope in Dusseldorf and BioMalaysia in Kuala Lumpur, and will be pleased to meet with interested parties during either meeting's formal partnering or by individual arrangement.

In 2011, GZP increased its global client base at all development phases across therapeutic areas such as oncology and neurological disease.  The firm created and submitted several INDs and SPAs and facilitated many pre-IND and mid-phase meetings with the FDA leading to rapid movement of client programs.  GZP believes that early, frequent, and creative FDA communication leads to more successful product development and attracts investors in today's difficult financial climate.

According to Evan Siegel, "We are pleased that the disappointing recovery from the global financial crisis has not diminished the entry of new intellectual property into the biotechnology and pharmaceutical space.  Our clients are determined to be successful and we are honored to provide support towards that end.  The expansion of our business is attributable to their trust in GZP, due to the excellence of our team which maintains an integrated and client-specific approach to deliver the highest quality services."

Based in Irvine, Ground Zero Pharmaceuticals, Inc. is a regulatory
'/>"/>

SOURCE Ground Zero Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pharmaceutical Industry Leaders to Tackle Groundbreaking Challenges, Opportunities for Pharma & Biotech at Elite Event
2. Rottenstein Law Group Heeds Groundswell of Grievances Against Manufacturers of Defective, Dangerous Hip Replacement Devices
3. Femasys and Norgenix Announce Distribution Agreement for Groundbreaking New Device for Infertility Diagnosis
4. Groundbreaking Report Details the New $80 Billion Accountable-Care Market
5. International Dyslexia Association Announces Groundbreaking Parent Membership Initiative in Response to 40,000 Annual Inquiries
6. Newborn Possibilities Fund Awards Grant to Georgia Health Sciences University Foundation to Support Groundbreaking Pediatric Research
7. Glenveigh Medical and Monica Healthcare Announce Distribution Agreement for Groundbreaking FDA Cleared Wireless Fetal Monitoring System
8. SinoFresh Healthcare, Inc. Takes Groundbreaking Products to Europe
9. Emerging Markets Are Gaining Ground in Medical Technology Innovation; U.S. Maintains Lead, Finds PwCs Medical Technology Innovation Scorecard
10. Groundbreaking Study Showed Bayers Advantage Multi® for Dogs (imidacloprid + moxidectin) Topical Solution was the only Heartworm Preventive Tested That Demonstrated 100 Percent Efficacy against the Challenging MP3 Strain
11. Pharma Industry Leaders to Reveal Hottest, Latest Trends for Pharma & Biotech at Groundbreaking Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... De Pfizer Clinical Research Unit (PCRU) heeft ... van Japanse komaf voor medewerking aan klinisch onderzoek. De ... één van twee onderzoekseenheden van Pfizer , een ... door de ontdekking en ontwikkeling van nieuwe medicijnen. Om ... mannen en vrouwen van Japanse komaf – leeftijd 18 ...
(Date:7/30/2014)... , July 30, 2014  Cepheid (Nasdaq: ... group purchasing contract with Premier will end on ... Premier GPO will be able to continue their ... Baycare, HPA, MedAssets, Novation, and ROi, in addition ... directly with Cepheid. "Cepheid has always ...
(Date:7/30/2014)... 2014 The Board of Directors of ... evening expressed support for the "Pharmacists, Patient Care ... Pharmacy Practitioners (JCPP).  As a JCPP member, AMCP ... period to develop a scalable, viable and consistent ... "Pharmacists are fast becoming one of the most ...
Breaking Medicine Technology:Gezonde vrijwilligers van Japanse komaf gezocht voor deelname aan Fase I klinisch onderzoek 2Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement 2Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement 3AMCP Endorses JCPP "Pharmacists' Patient Care Process" 2
... Reportlinker.com announces that a new market ... Commercial Insight: Antihormonal Cancer ... generic sales erosion ... therapies are a class of drugs used ...
... NEW YORK, Nov. 8, 2010 Reportlinker.com ... is available in its catalogue: ... for optimizing growth in key regions and ... The flurry of recent ...
Cached Medicine Technology:Commercial Insight: Antihormonal Cancer Therapies - Leading Brands Strive to Minimize Generic Sales Erosion 2Commercial Insight: Antihormonal Cancer Therapies - Leading Brands Strive to Minimize Generic Sales Erosion 3Commercial Insight: Antihormonal Cancer Therapies - Leading Brands Strive to Minimize Generic Sales Erosion 4Commercial Insight: Antihormonal Cancer Therapies - Leading Brands Strive to Minimize Generic Sales Erosion 5Commercial Insight: Antihormonal Cancer Therapies - Leading Brands Strive to Minimize Generic Sales Erosion 6Commercial Insight: Antihormonal Cancer Therapies - Leading Brands Strive to Minimize Generic Sales Erosion 7Commercial Insight: Antihormonal Cancer Therapies - Leading Brands Strive to Minimize Generic Sales Erosion 8Commercial Insight: Antihormonal Cancer Therapies - Leading Brands Strive to Minimize Generic Sales Erosion 9Opportunities in Emerging Pharma Markets: Strategies for Optimizing Growth in Key Regions and Therapeutic Areas 2Opportunities in Emerging Pharma Markets: Strategies for Optimizing Growth in Key Regions and Therapeutic Areas 3Opportunities in Emerging Pharma Markets: Strategies for Optimizing Growth in Key Regions and Therapeutic Areas 4Opportunities in Emerging Pharma Markets: Strategies for Optimizing Growth in Key Regions and Therapeutic Areas 5Opportunities in Emerging Pharma Markets: Strategies for Optimizing Growth in Key Regions and Therapeutic Areas 6Opportunities in Emerging Pharma Markets: Strategies for Optimizing Growth in Key Regions and Therapeutic Areas 7
(Date:7/31/2014)... 31, 2014 Quincy Bioscience, a fast-growing ... health supplement Prevagen®, releases the second edition of the ... for Making Memories: Birth of a Grandchild. , ... exceptional memory-making tips and ideas for grandparents to utilize ... a grandchild. Each concept published in the e-book is ...
(Date:7/31/2014)... FL. (PRWEB) July 31, 2014 ... USARAD Holdings Inc. a leading US Joint Commission ... the most innovative and technologically advanced consumer storage ... The teleradiology leader is providing valued members the ... enhancing the extraordinary services already offered by SecondOpinions.com®. ...
(Date:7/31/2014)... During an annual summer didactic and live ... Dallas plastic surgeon and a member of the ... demonstration of facial anatomy and key advances in facial ... Summer Meeting of the Cosmetic Bootcamp included lectures, anatomical ... key principles in modern facial surgery. , One of ...
(Date:7/31/2014)... July 31, 2014 Body Well Therapy ... insurance patients seeking massage therapy in all 44 states ... option for Licensed Massage Therapists who do not otherwise ... to BWT. Should a patient request a specific qualified ... can then contract the therapist to provide therapeutic massage ...
(Date:7/31/2014)... 2014 Cheerag D. Upadhyaya ... neurosurgeons at the Saint Luke’s Marion Bloch Neuroscience ... director of spine surgery. He comes to SLMBNI from ... Upadhyaya has been recognized for his excellent work, research ... His addition to the Saint Luke’s Marion Bloch Neuroscience ...
Breaking Medicine News(10 mins):Health News:Quincy Bioscience Launches the Second E-Book of the Making Memories Series 2Health News:SECONDOPINIONS.COM® Introduces Innovative Cloud-Based Medical Imaging Exchange Service for Easy Upload, Access and Sharing Anytime/Anywhere 2Health News:SECONDOPINIONS.COM® Introduces Innovative Cloud-Based Medical Imaging Exchange Service for Easy Upload, Access and Sharing Anytime/Anywhere 3Health News:Dr. Rod J. Rohrich Demonstrates Advances in Facial Surgery at Annual Cosmetic Surgery Seminar 2Health News:Dr. Rod J. Rohrich Demonstrates Advances in Facial Surgery at Annual Cosmetic Surgery Seminar 3Health News:Body Well Therapy Invites Massage Therapists Nationwide to "Bring Your Own Insurance Clients" 2Health News:Body Well Therapy Invites Massage Therapists Nationwide to "Bring Your Own Insurance Clients" 3Health News:Saint Luke’s Marion Bloch Neuroscience Institute welcomes Cheerag D. Upadhyaya, M.D., as director of Spine Program 2Health News:Saint Luke’s Marion Bloch Neuroscience Institute welcomes Cheerag D. Upadhyaya, M.D., as director of Spine Program 3Health News:Saint Luke’s Marion Bloch Neuroscience Institute welcomes Cheerag D. Upadhyaya, M.D., as director of Spine Program 4
... ... top of the world and sharing her story of hope and determination. , ... Bayfield, WI (PRWEB) April 7, 2010 -- Hopeful climbers have ... to climb the world,s highest peak. Last year,s successful climbers whose summit of Everest ...
... ... to Win an Appearance on National Television—or Win an Apple iPad™ in the “Best Seller ... ... lead to TODAY’S publishing of Gerry Czarnecki’s latest book… Lead with Love. This is ...
... researchers of over eight years of dietary data from more ... consumption of fruits and vegetables and a reduced risk of ... is published online April 6, 2010 in the Journal ... believed that a diet rich in fruits and vegetables can ...
... at initial screening often didn,t have recommended colonoscopy, study ... Americans are less likely than whites to have a ... sigmoidoscopy screening test, says a new study. , ... risk for colorectal cancer and more likely to die ...
... say , TUESDAY, April 6 (HealthDay News) -- The use ... in the past six years, even though these operations ... necessarily more effective, a study finds. , "It was a ... was," said Dr. Richard A. Deyo, professor of family medicine ...
... previously used exclusively by academic researchers has successfully been ... national strategies to curtail the spread of HIV, meaning ... , A new study by researchers at the University ... would work when led by CBOs, who have played ...
Cached Medicine News:Health News:Woman with MS Summits Everest and Completes the Seven Summits 2Health News:Woman with MS Summits Everest and Completes the Seven Summits 3Health News:‘Leading' the Bestseller Race: Today We Publish —Tomorrow We Prevail! 2Health News:‘Leading' the Bestseller Race: Today We Publish —Tomorrow We Prevail! 3Health News:Mount Sinai study finds only a weak link between fruit and vegetable and reduced risk of cancer 2Health News:Blacks Less Likely to Get Follow-Up Colon Screening 2Health News:Complex Spinal Operations Soar Despite Drawbacks 2Health News:Complex Spinal Operations Soar Despite Drawbacks 3Health News:Roll-out of proven HIV/STD risk-reduction intervention with teens by community groups successful 2
... As a prophylaxis for deep vein ... effective combination of graduated sequential compression and ... thrombus formation by increasing venous ejection while ... VenaFlow System includes a pump with tube ...
... Full Transportability: Innovative design allows the ... in for therapy or when to ... Choose the prophylactic method to deliver ... both simultaneously. ,Automatic Garment Detection: Automatically ...
... boot specially lasted for fiberglass casts... ... sole for easy ambulation! ,The SlimLine ... last so it fits better than ... with our stretchable upper, a custom ...
The Low Profile boot provides a durable canvas upper, with an open toe and heel. Padded EVA insole protection. The lower outsole compensates for casting thickness. Available in six unisex sizes....
Medicine Products: